Company Description
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States.
The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation.
It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013.
Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
| Country | United States |
| Founded | 2011 |
| IPO Date | May 22, 2020 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,300 |
| CEO | Andrew Hykes |
Contact Details
Address: 6001 Oak Canyon, Suite 100 Irvine, California 92618 United States | |
| Phone | 877 923 4747 |
| Website | inarimedical.com |
Stock Details
| Ticker Symbol | NARI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $19.00 |
| CIK Code | 0001531048 |
| CUSIP Number | 45332Y109 |
| ISIN Number | US45332Y1091 |
| Employer ID | 45-2902923 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Andrew J. Hykes | Chief Executive Officer, President and Director |
| Dr. Thomas M. Tu M.D. | Chief Medical Officer |
| Paul A. Koehn | Senior Vice President of Operations |
| John Hsu C.F.A. | Vice President of Investor Relations |
| Eric Khairy | Senior Vice President of Marketing |
| Tim A. Benner | Senior Vice President of Sales and Senior VP of U.S. Sales |
| Tara Dunn | Senior Vice President and GM of LimFlow |
| Brian Strauss | Senior Vice President of Engineering |
| Dr. Shon Chakrabarti M.D., M.P.H. | Chief Medical Officer of LimFlow |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 18, 2024 | 144 | Filing |
| Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 7, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Oct 29, 2024 | 144 | Filing |
| Oct 28, 2024 | 10-Q | Quarterly Report |
| Oct 28, 2024 | 8-K | Current Report |
| Oct 23, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Sep 12, 2024 | 144 | Filing |
| Aug 19, 2024 | 144 | Filing |